IAS 2015 Towards an HIV Cure symposium
Vancouver
Considerations about combination
anti-latency strategies and the
needs and concerns of PLWHIV
Risk versus benefits
• How to manage excitement about progress
in cure research.
• Will combination strategies necessitate
treatment interruptions to determine their
effect? What are the various concerns?
• What will be the impact of immune
modulating components that have a longlasting effect?
• Will combination strategies increase the
complexity of informed consents?